eMIONs: novel genetically engineered nanocages for magnetic hyperthermia cancer therapy
The clinical introduction of magnetic hyperthermia therapy (MHT) has been hindered by current available agents with poor magnetic-to-thermal conversion efficiency and biocompatibility. It is believed that the genetically engineered magnetic nanocages of encapsulin-produced magnetic iron oxide nanoco...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis Group
2021-01-01
|
| Edice: | Molecular & Cellular Oncology |
| Témata: | |
| On-line přístup: | http://dx.doi.org/10.1080/23723556.2020.1863739 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|